Wednesday, November 9, 2016
Doctors Caminear and DeLott participate in FDA study and are the first in Northeast to offer the new Storz Duolith® SD1 non-surgical technology.
HAMDEN, CT [November 9, 2016] - Due to its participation in a U.S. Food and Drug Administration (FDA) study, Connecticut Orthopaedic Specialists is able to offer a new, non-surgical treatment for plantar fasciitis and other tendonitis conditions. The new technology, the Storz Duolith SD1, provides a more effective Extracorporeal Shock Wave Therapy, during a routine office visit which does not require anesthesia. The new technology was recently approved by the FDA for treatment of chronic plantar fasciitis. It also can be used to treat tennis elbow, Achilles tendonitis, and knee tendonitis.
Two Connecticut Orthopaedic Specialists (COS) doctors, David Caminear and Jeffrey DeLott participated in the FDA study and have treated more than 50 patients using Storz Duolith Extracorporeal Shock Wave Therapy with at least a 70% success rate. COS predicts that patients treated with the new treatment will increase by 25% in the coming year. Dr. Caminear was also one of the authors of the final study that was published in The Journal of Bone and Joint Surgery.
“Connecticut Orthopaedic Specialists was selected as one of six sites to perform an FDA study in order to gain approval for the new innovative technology to treat plantar fasciitis,” stated Dr. Caminear. “As a result of that, we currently are the only practice in New England that has this technology and we are able to provide that to our patients.”
The treatment, which is essentially a ten-minute office visit once a week for three to five weeks, uses acoustic waves to initiate a healing response in specific areas. The procedure resembles an ultrasound with patients seated, their foot elevated and the doctor applying a jelly to the affected area. A small, handheld applicator is then pressed against the foot and targets sound waves to that same area.
“The patients can show a response without anything surgical,” noted Dr. DeLott. “So it’s really a non-invasive type treatment that can be utilized prior to anything surgical.” Because, in most cases surgery can be avoided, this new innovation is less expensive, more effective, and because it is less invasive, recovery time is also reduced.
Joseph Soultatos is a pharmacist who had suffered from plantar fasciitis and underwent Extracorporeal Shock Wave Therapy. “Standing between eight and twelve hours a day gets to be quite unbearable when the duration of your day is coupled with a great deal of pain. After going through four sessions of the Extracorporeal Shock Wave Therapy I have had a massive reduction in the amount of pain I deal with, which for me, makes me want to dance. It was a great feeling not waking up and taking that first painful step in the morning.”
Connecticut Orthopaedic Specialists, PC offers all orthopaedic subspecialties including sports medicine, treatment for problems of the upper extremities and lower extremities, joint replacement surgery, pediatric orthopaedics, and surgical and non-surgical podiatry. It is one of the most respected orthopaedic groups in Connecticut and has been providing quality, individualized care to patients for over 50 years. COS has eight locations with in-house physical therapy, three OrthoNOW orthopaedic walk-in centers, two MRI centers providing in-house diagnostic testing and its own surgical center.
For more information, please contact Ron Thompson at email@example.com or call 203.407.3580